Several studies have highlighted the upregulated expression of NAMPT in various cancers, including colorectal, breast, ovarian, endometrial, prostate, and pancreatic cancers, with higher NAMPT expression often being correlated with poorer survival outcomes [100,101,102,103,104]. This evidence concerns the gene NAMPT and pancreatic neoplasm.